| Name | Cvs Pharmacy #06346 |
|---|---|
| Organization Name | Kentucky Cvs Pharmacy Llc |
| Location | 409 E Main St, Richmond, Kentucky 40475 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (859) 623-7481 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Only one in ten respondents to a Harris Interactive survey use electronic medical records or interact with their doctors by e-mail, HealthDay/Bloomberg Businessweek reports. Half were unsure whether their doctors even use these technologies. "Still, most of those polled said they would like their doctors to access their medical records with the click of a mouse. On the other hand, only about a third (30 percent) believe their insurer should have that same access."
Researchers from the University at Buffalo at The State University of New York examined the effects of pre-existing post traumatic stress disorder (PTSD) on mechanically ventilated veterans during ICU hospitalization. This retrospective cohort study found that mechanically ventilated patients with PTSD had higher sedation requirements.
The Perelman School of Medicine at the University of Pennsylvania has launched the Penn Center for Advanced Retinal and Ocular Therapeutics (CAROT) to build on its previous success developing novel therapies for the personalized diagnosis and treatment of retinal and ocular disorders.
Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that it has signed a definitive agreement to acquire Nellix, Inc, a privately-held medical device company that has developed a revolutionary endograft for the treatment of Abdominal Aortic Aneurysms (AAAs).
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ERWINASE(R) (L-asparaginase derived from Erwinia chrysanthemi) for use in the treatment of acute lymphoblastic leukemia in patients with hypersensitivity to E. coli-derived asparaginase.
› Verified 9 days ago
| NPI Number | 1003919754 |
| Organization Name | KENTUCKY CVS PHARMACY, L.L.C. |
| Doing Business As | CVS PHARMACY # 06346 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 409 E Main St, Richmond, KY 40475 |
| Phone Number | 859-623-7481 |
News Archive
Only one in ten respondents to a Harris Interactive survey use electronic medical records or interact with their doctors by e-mail, HealthDay/Bloomberg Businessweek reports. Half were unsure whether their doctors even use these technologies. "Still, most of those polled said they would like their doctors to access their medical records with the click of a mouse. On the other hand, only about a third (30 percent) believe their insurer should have that same access."
Researchers from the University at Buffalo at The State University of New York examined the effects of pre-existing post traumatic stress disorder (PTSD) on mechanically ventilated veterans during ICU hospitalization. This retrospective cohort study found that mechanically ventilated patients with PTSD had higher sedation requirements.
The Perelman School of Medicine at the University of Pennsylvania has launched the Penn Center for Advanced Retinal and Ocular Therapeutics (CAROT) to build on its previous success developing novel therapies for the personalized diagnosis and treatment of retinal and ocular disorders.
Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that it has signed a definitive agreement to acquire Nellix, Inc, a privately-held medical device company that has developed a revolutionary endograft for the treatment of Abdominal Aortic Aneurysms (AAAs).
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ERWINASE(R) (L-asparaginase derived from Erwinia chrysanthemi) for use in the treatment of acute lymphoblastic leukemia in patients with hypersensitivity to E. coli-derived asparaginase.
› Verified 9 days ago
News Archive
Only one in ten respondents to a Harris Interactive survey use electronic medical records or interact with their doctors by e-mail, HealthDay/Bloomberg Businessweek reports. Half were unsure whether their doctors even use these technologies. "Still, most of those polled said they would like their doctors to access their medical records with the click of a mouse. On the other hand, only about a third (30 percent) believe their insurer should have that same access."
Researchers from the University at Buffalo at The State University of New York examined the effects of pre-existing post traumatic stress disorder (PTSD) on mechanically ventilated veterans during ICU hospitalization. This retrospective cohort study found that mechanically ventilated patients with PTSD had higher sedation requirements.
The Perelman School of Medicine at the University of Pennsylvania has launched the Penn Center for Advanced Retinal and Ocular Therapeutics (CAROT) to build on its previous success developing novel therapies for the personalized diagnosis and treatment of retinal and ocular disorders.
Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that it has signed a definitive agreement to acquire Nellix, Inc, a privately-held medical device company that has developed a revolutionary endograft for the treatment of Abdominal Aortic Aneurysms (AAAs).
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ERWINASE(R) (L-asparaginase derived from Erwinia chrysanthemi) for use in the treatment of acute lymphoblastic leukemia in patients with hypersensitivity to E. coli-derived asparaginase.
› Verified 9 days ago
Bluegrass Family Pharmacy, Inc. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2187 Lexington Rd, Richmond, Kentucky 40475 Phone: (859) 624-9797 | |
Dr. David B. Coleman Type: Medicare Supplier Location: 523 Leighway Dr, Richmond, Kentucky 40475 Phone: (859) 623-6812 | |
The Medicine Shoppe #654 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 238 E Main St, Richmond, Kentucky 40475 Phone: (859) 623-8900 | |
Visionworks Doctors Of Optometry Type: Eyewear Supplier (Equipment, not the service) Location: 2115 Lantern Ridge Dr, Richmond, Kentucky 40475 Phone: (859) 625-1004 | |
Eye Care Center Optometrist Psc Type: Medicare Supplier Location: 1020 Gibson Bay Dr, Richmond, Kentucky 40475 Phone: (859) 623-3358 |